Albert Cha, Director at KalVista Pharmaceuticals, Inc. (KALV), sold 18,000 shares at $10.50 ($189K) on 2023-09-11, disclosed to the SEC on 2023-09-13.
Open-market sale of $189k KALV by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| KALV | BUY | 2019-07-19 | $2.2M | — | Filing → |
| KALV | BUY | 2018-09-12 | $18.0M | — | Filing → |
| MNLO | BUY | 2018-01-29 | $5.0M | — | Filing → |